SOD1 and amyotrophic lateral sclerosis: Notably, this drug was not tested in the canonical SOD1 transgenic mouse model of ALS before moving to clinical trials, as the human cell-based data was deemed sufficient (Mcneish et al., 2015; Wainger et al., 2021).